1. Verkhodanova V, Coler M, Jonkers R, Lowie W. How expertise and language familiarity influence perception of speech of people with Parkinson's disease. Clinical Linguistics & Phonetics. 2022; 36(2-3):165-82. [DOI:10.1080/02699206.2021.2003433]

2. Ungprasert P, Srivali N, Thongprayoon C. Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis. Parkinsonism & Related Disorders. 2015; 21(10): 1238-42. [DOI:10.1016/j.parkreldis.2015.08.030]

3. Lutz SG, Holmes JD, Ready EA, Jenkins ME, Johnson AM. Clinical presentation of anxiety in Parkinson's disease: a scoping review. OTJR: Occupation, Participation and Health. 2016; 36(3): 134-47. [DOI:10.1177/1539449216661714]

4. Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, et al. Prodromal markers in parkinson's disease: limitations in longitudinal studies and lessons learned. Frontiers in Aging Neuroscience. 2016; 8: 147. [DOI:10.3389/fnagi.2016.00147]

5. Mariani E, Frabetti F, Tarozzi A, Pelleri MC, Pizzetti F, Casadei R. Meta-analysis of parkinson's disease transcriptome data using tram software: whole substantia nigra tissue and single dopamine neuron differential gene expression. PloS One. 2016; 11(9): e0161567. [DOI:10.1371/journal.pone.0161567]

6. Kano M, Takayanagi T, Harada K, Makino K, Ishikawa F. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoera batatas cultivar Ayamurasaki. Bioscience, biotechnology, and biochemistry. 2005; 69(5): 979-88. [DOI:10.1271/bbb.69.979]

7. Gonda R, Tomoda M, Kanari M, Shimizu N, et al. Constituents of the seed of Malva verticillata, VI, Characterization and immunological activities of a novel acidic polysaccharide.Chem Pharm Bull (Tokyo). 1990; 10: 2771-4. [DOI:10.1248/cpb.38.2771]

8. Zargari A. medicinal plants.Tehran: University of Tehran; 2007.

9. Scorrano S, Lazzoi MR, Mergola L, Di Bello MP, Del Sole R, Vasapollo G. Anthocyanins profile by Q-TOF LC/MS in Myrtus communis berries from Salento Area. Food Analytical Methods. 2017; 10: 2404-11. [DOI:10.1007/s12161-017-0813-6]

10. Yeole NB, Sandhya P, Chaudhari PS, Bhujbal PS. Evaluation of Malva sylvestris and Pedalium murex mucilage as suspending agent. International Journal of PharmTech Research. 2010; 2(1): 385-9.

11. Esteves PF, Sato A, Esquibel MA, de Campos-Buzzi F, Meira AV, Cechinel-Filho V. Antinociceptive activity of Malva sylvestris L. Lat Am J Pharm. 2009; 28(3): 454-6.

12. Ghasemi Z, Kiasalari Z, Ebrahimi F, Ansari F, Sharayeli M, Roghani M. Neuroprotective effect of diosgenin in 6-hydroxydopamine-induced model of Parkinsonâ s disease in the rat. Daneshvar Medicine. 2017; 25(2): 87-98.

13. Nikokalam Nazif N, Khosravi M, Ahmadi R, Bananej M, Majd A. The effect of ghrelin hormone on level of tumor necrosis factor alpha and gene expression of cytochrome b and interleukin 10 in substantia nigra in an animal model of Parkinson's disease. Iranian Journal of Physiology and Pharmacology. 2019; 3(1): 63-73.

14. Nikokalam Nazif N, Khosravi M, Ahmadi R, Bananej M, Majd A. Neuroprotective Effect of Quercetin in 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine-Induced Model of Parkinson's Disease. The Neuroscience Journal of Shefaye Khatam. 2019; 8(1):1-10. [DOI:10.29252/shefa.8.1.1]

15. Terohid SF, Mirazi M, Sarihi A. Study of hepatoprotective effect of Malva neglecta L. hydroethanolic leaf extract in male rat induced with carbon tetrachloride. Journal of Cell & Tissue. 2015; 5(1): 31-42.

16. Mohanakumar KP, Thomas B, Sharma SM, Muralikrishnan D, Chowdhury R, Chiueh CC. Nitric oxide: an antioxidant and neuroprotector. Annals of the New York Academy of Sciences. 2002; 962(1): 389-401. [DOI:10.1111/j.1749-6632.2002.tb04083.x]

17. Yarijani ZM, Godini A, Madani SH, Najafi H. Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract. Biomedicine & Pharmacotherapy. 2018; 106: 1767-74. [DOI:10.1016/j.biopha.2018.07.115]

18. Mousavi SM, Hashemi SA, Behbudi G, Mazraedoost S, Omidifar N, Gholami A, Chiang WH, Babapoor A, Pynadathu Rumjit N. A review on health benefits of Malva sylvestris L. nutritional compounds for metabolites, antioxidants, and anti-inflammatory, anticancer, and antimicrobial applications. Evidence-Based Complementary and Alternative Medicine. 2021; 1-13. [DOI:10.1155/2021/5548404]

19. Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nature Reviews Neuroscience. 2015; 16(5): 249-63. [DOI:10.1038/nrn3898]

20. Zhang X, Zhang R, Awan MU, Bai J. The Mechanism and Function of Glia in Parkinson's Disease. Frontiers in Cellular Neuroscience. 2022; 16. [DOI:10.3389/fncel.2022.903469]

21. Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nature Reviews Neuroscience. 2014; 15(5): 300-12. [DOI:10.1038/nrn3722]

22. Biondetti E, Santin MD, Valabregue R, Mangone G, Gaurav R, Pyatigorskaya N, et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease. Brain. 2021; 144: 3114-3125. [DOI:10.1093/brain/awab191]

23. Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, et al. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. J. Neuroinflammation. 2021; 18: 295. [DOI:10.1186/s12974-021-02349-y]

24. Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat. Commun. 2020; 11: 1386. [DOI:10.1038/s41467-020-15119-w]